Received May 14, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y020531 | IM / LA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y020531 | OT / LA |
No symptomatic events were reported; temperature excursion/the medication error occurred; This spontaneous report has been received from a medical assistant and refers to a 12-year-old male patient. The patient's concurrent conditions included hypercholesterolemia. The patient's historical conditions, past medications and concomitant medications were not reported. On 20-FEB-2026, the patient was vaccinated with 1st dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection (batch/lot number Y020531, confirmed valid with an expiry date of 05-AUG-2027) administered intramuscularly into the left arm for prophylaxis (exact dose was not reported). Before administration, the vaccine underwent temperature excursion; it was reported that a medication error occurred (Product storage error). No symptomatic events were reported (No adverse event). This is one of several reports received from the same reporter.
Hypercholesterolemia